Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

At 6.5% CAGR, Global Albumin Market Size & Share Will Hit US$ 9.55 Billion by 2028 | Industry Trends, Demand, Growth, Value, Analysis & Forecast Report by Zion Market Research

This image opens in the lightbox

News provided by

Zion Market Research

18 Aug, 2022, 15:30 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, Aug. 18, 2022 /PRNewswire/ -- As per Zion Market Research study, The global albumin market grasped a market value of USD 4.25 billion in 2021. The market is expected to expand at a CAGR of 6.5 percent to reach around USD 9.55 billion by 2028.

Albumin Market: Overview                                           

A few animal cells are used to make synthetic meat in a lab. It is real meat, but unlike traditional meat, it doesn't require killing animals. The goal is to create an ethical and sustainable beef industry from an environmental standpoint. Some industry experts believe that the "cellular agriculture" technology used to make meat is the way of the future. Chronic diseases may be exacerbated by meat consumption. Though scientists can change the amount of fat and cholesterol in cultured meat, the evidence isn't clear about the potential consequences of lab-grown meat on nutrition. Artificial meats are much less likely to contain the E. coli bacteria found in animal feces and other contaminants that could be present in a meat processing factory. Artificial meat is also less harmful to the environment and less cruel to animals.

Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/albumin-market

Our Free Sample Report Includes:

  • 2022 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 190 + Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes an Updated List of tables & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Zion Market Research methodology

Key Industry Insights & Findings of the Albumin Market Reports:

  • As per the analysis shared by our research analyst, the Albumin Market is expected to grow annually at a CAGR of around 6.5 % (2022-2028).
  • Through the primary research, it was established that the Albumin Market was valued at approximately USD 4.2 billion in 2021 and is projected to reach roughly USD 9 billion by 2028.
  • Extensive use of albumin in vaccine preparation is expected to boost the global market during the forecast period. The growing awareness of recombinant albumin products & their benefits is expected to become a chief global market driver during the projection period.
  • Adverse reactions like ankle & leg swelling, itching or skin rash, breathing difficulties, and discoloration of lips & fingertips due to albumin-related products are anticipated to restrain the global market growth.
  • The global market is witnessing a rise in demand for serum-free solutions given the lesser risk of contamination in serum-free solutions along with easier purification. The shift in preference is anticipated to act as a restraining agent in the global market.
  • World leaders have started investing in large-scale production which can reduce expenses making the global market cost-effective and providing for more opportunities in the global market.
  • The unexplored market size of Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period owing to increasing demand for vaccines and heavy investments in the healthcare sector.
  • These regions have a high per capita capacity for medical expenditure and are expected to carry the same growing trend in the global market during the projection period.
  • The Middle East has been showing steady signs of market growth caused by rising health awareness amongst the consumer group and better healthcare policies.

Zion Market Research published the latest report titled "Albumin Market By Product (Human Serum Albumin, Bovine Serum Albumin, And Recombinant Albumin), By Application (Therapeutics, Diagnostics, Drug Delivery, Vaccine Ingredient, Culture Medium Ingredient & Stabilizer, In-Vitro Fertilization, And Others), By End-User (Pharmaceutical & Biotechnology Industry, Research Institutes, And Others), And By Region: Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028." into their research database.

Industry Dynamics:

Albumin Market: Growth Drivers

  • Rise in rare medical cases along with non-therapeutic use of Albumin to propel global market growth.

With advancements in technology, the detection of rare diseases which can be effectively treated with albumin has increased. This is projected to instill a rise in the global market value of albumin.

Extensive use of albumin in vaccine preparation is expected to boost the global market during the forecast period. The growing awareness of recombinant albumin products & their benefits is expected to become a chief global market driver during the projection period.

Furthermore, the rise in competition and subsequent expansion of companies in the global market is expected to push the global market growth.

Albumin Market: Restraints

  • Irrational usage and adverse reactions related to albumin to restraint global market growth.

An increase in the irrational use of albumin is anticipated to restrain the global albumin market growth during the forecast period. Irrational use includes hypoproteinemia and nutritional support. This is caused by a non-essential or unsuitable prescription of albumin. Adverse reactions like ankle & leg swelling, itching or skin rash, breathing difficulties, and discoloration of lips & fingertips due to albumin-related products are anticipated to restrain the global market growth.

Increase in preference for serum-free solutions to cause a glitch in global market growth.

The global market is witnessing a rise in demand for serum-free solutions given the lesser risk of contamination in serum-free solutions along with easier purification. The shift in preference is anticipated to act as a restraining agent in the global market.

Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/albumin-market

Global Albumin Market: Opportunities

  • Potential untapped market and cost-effective large scale production to provide growth opportunities to the global market

A lot of undeveloped or developing economies have a tremendous amount of untapped potential in the global market. This provides a great opportunity for market leaders to explore. World leaders have started investing in large-scale production which can reduce expenses making the global market cost-effective and providing for more opportunities in the global market.

  • Increasing awareness of better health to bring growth opportunities in the global market

There has been a rising awareness amongst the general population for better health. This has ultimately emphasized the drug development process. The rise in drug demands is anticipated to provide growth opportunities in the global market during the forecast period.

Global Albumin Market: Challenges

  • Government regulations and substitute products pose challenges to the global market growth.

There are several government regulations laid down by every country. These regulations hamper the smooth development and distribution of albumin creating unfavorable conditions for the global market growth. There has been an increase in the development of substitutes like sodium chloride solutions for albumin. The rise in alternatives to albumin poses a major challenge in the global albumin market.

  • Supplier's bargaining power and increasing competition to create challenging situations in the global market.

With the rise in demand for albumin, there has been a significant shift in the bargaining power of the suppliers. Additionally, the global competition has been increasing tremendously which is projected to create challenging situations in the global market.

Get More Insight before Buying@: https://www.zionmarketresearch.com/inquiry/albumin-market

List of Key Players in Albumin Market:

  • Baxter International Inc.
  • Akron Biotech
  • Octapharma AG
  • HiMedia Laboratories Pvt. Ltd.Grifols SA
  • Takeda Pharmaceuticals Inc
  • Mitsubishi Tanabe Pharma Corporation
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • China Biologic Products Inc
  • Sigma-Aldrich Co. LLC.
  • Novozymes
  • CSL Limited
  • Ventria Bioscience
  • Medxbio Pte Ltd.

Key questions answered in this report:

  • What are the growth rate forecast and market size for Albumin Market?
  • What are the key driving factors propelling the Albumin Market forward?
  • What are the most important companies in the Albumin Market Industry?
  • What segments does the Albumin Market cover?
  • How can I receive a free copy of the Albumin Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market size value in 2021

USD 4.2 Billion

Revenue forecast in 2028

USD 9 Billion

Growth Rate

CAGR of almost 6.5 % 2022-2028

Base Year

2020

Historic Years

2016 – 2021

Forecast Years

2022 – 2028

Segments Covered

By Product Type, By Application, And By End Use

Forecast Units

Value (USD Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2022 to 2028

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others

Companies Covered

Baxter International Inc., Akron Biotech, Octapharma AG, HiMedia Laboratories Pvt. Ltd.Grifols, SA, Takeda Pharmaceuticals Inc, Mitsubishi Tanabe Pharma Corporation, Merck KGaA, Thermo Fisher Scientific Inc., China Biologic Products, Inc, Sigma-Aldrich Co. LLC., Novozymes, CSL Limited, Ventria Bioscience, Medxbio Pte Ltd.

Report Coverage

Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization Scope

Avail of customized purchase options to meet your exact research needs.  

https://www.zionmarketresearch.com/custom/3434

 Free Brochure: https://www.zionmarketresearch.com/requestbrochure/albumin-market

Recent Developments

  • In March 2020, FDA approved the use of the Pumotech MAA kit to Curium Pharma. The kit is used to prepare technetium Tc 99m Albumin aggregated injection. The injection is used for lung imaging and evaluation of pulmonary perfusion. The injection acts as a single-photon emission agent.
  • May 2020 witnessed the announcement by Bio Products Laboratory for the US launch of Albuminex 5% and Albuminex 25% solutions to be used for injection. The injection is FDA approved and is used in treatment related to burns, cardiopulmonary bypass, acute nephrosis, and ARDS.

Regional Dominance:

  • Rising health awareness amongst the consumer group and better healthcare policies.

The unexplored market size of Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period owing to increasing demand for vaccines and heavy investments in the healthcare sector. This is followed by Europe and North America because of greater awareness and acceptance of the drugs. These regions have a high per capita capacity for medical expenditure and are expected to carry the same growing trend in the global market during the projection period.

The Middle East has been showing steady signs of market growth caused by rising health awareness amongst the consumer group and better healthcare policies. Africa is projected to grow relatively slower because of poor infrastructure and lack of research or treatment facilities. The slow economic growth along with restricted access to resources is also a contributing factor to the slow development during the forecast period.

Global Albumin Market is segmented as follows:

Albumin Market: By Product Outlook (2022-2028)

  • Human serum albumin
  • Bovine serum albumin
  • Recombinant albumin

Albumin Market: By Application Outlook (2022-2028)

  • Therapeutics
  • Diagnostics
  • Drug delivery
  • Vaccine ingredient
  • Culture medium
  • Ingredient & stabilizer
  • In-vitro fertilization

Albumin Market: By End-User Outlook (2022-2028)

  • Pharmaceutical & biotechnology industry
  • Research institutes

Albumin Market: By Region Outlook (2022-2028)

North America

  • The U.S.
  • Canada

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Press Release For Albumin Market: https://www.zionmarketresearch.com/news/global-albumin-market

Browse Other Related Research Reports from Zion Market Research

  • Cannabis Cultivation Market - Global Industry Analysis: The global Cannabis Cultivation Market accrued earnings worth approximately 147.3 (USD Billion) in 2020 and is predicted to gain revenue of about 359.6 (USD Billion) by 2028, is set to record a CAGR of nearly 14.5% over the period from 2021 to 2028.
  • Pharmaceutical Sterility Testing Market - Global Industry Analysis: The global Pharmaceutical Sterility Testing Market accrued earnings worth approximately 1.2(USD Billion) in 2020 and is predicted to gain revenue of about 2.3 (USD Billion) by 2028, is set to record a CAGR of nearly 11.9% over the period from 2021 to 2028.
  • Respiratory Disorders Treatment Market - Global Industry Analysis: The global Respiratory Disorders Treatment market accrued earnings worth approximately 98.9 (USD Billion) in 2020 and is predicted to gain revenue of about 112.5(USD Billion) by 2028, is set to record a CAGR of nearly 6.1% over the period from 2021 to 2028.

Browse through Zion Market Research's coverage of the Global Pharmaceutical Industry

Follow Us on: LinkedIn | Twitter | Facebook

About Us

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/

Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.